These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8418074)

  • 41. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
    Tay EH; Yew WS; Ho TH
    Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis.
    Teshima S; Shimosato Y; Kishi K; Kasamatsu T; Ohmi K; Uei Y
    Cancer; 1985 Jul; 56(1):167-72. PubMed ID: 4005786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
    Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
    Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative cytologic features of adenocarcinoma in situ of the uterine cervix.
    Lee KR; Manna EA; Jones MA
    Acta Cytol; 1991; 35(1):117-26. PubMed ID: 1994620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histogenesis of cervical adenocarcinoma with reference to human papillomavirus-18 as a carcinogen.
    Okagaki T; Tase T; Twiggs LB; Carson LF
    J Reprod Med; 1989 Sep; 34(9):639-44. PubMed ID: 2553963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invasive carcinoma after cone biopsy for cervical intraepithelial neoplasia.
    Brown JV; Peters WA; Corwin DJ
    Gynecol Oncol; 1991 Jan; 40(1):25-8. PubMed ID: 1989911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cervical carcinoma with glandular differentiation: histological evaluation predicts disease recurrence in clinical stage I or II patients.
    Costa MJ; McIlnay KR; Trelford J
    Hum Pathol; 1995 Aug; 26(8):829-37. PubMed ID: 7635446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix: a case report.
    Lu FH; Chen BF; Yang YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):436-40. PubMed ID: 9699398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe cervical glandular cell lesions with coexisting squamous cell lesions.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):218-27. PubMed ID: 15368313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervical adenocarcinoma in situ.
    Hopkins MP; Roberts JA; Schmidt RW
    Obstet Gynecol; 1988 Jun; 71(6 Pt 1):842-4. PubMed ID: 3285263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Microglandular endocervical hyperplasia and endocervical adenocacinoma in pregnant--description of two cases].
    Nikolova M; Marinov E; Stoĭkov S; Gorchev G; Tomov S
    Akush Ginekol (Sofiia); 2005; 44(2):41-3. PubMed ID: 15853028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus DNA in glandular dysplasia and microglandular hyperplasia: presumed precursors of adenocarcinoma of the uterine cervix.
    Tase T; Okagaki T; Clark BA; Twiggs LB; Ostrow RS; Faras AJ
    Obstet Gynecol; 1989 Jun; 73(6):1005-8. PubMed ID: 2542853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ.
    Goldstein NS; Mani A
    Am J Clin Pathol; 1998 Jun; 109(6):727-32. PubMed ID: 9620030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Occurrence and histological structure of adenocarcinoma of the endocervix after long-term use of oral contraceptives (author's transl)].
    Dallenbach-Hellweg G
    Geburtshilfe Frauenheilkd; 1982 Apr; 42(4):249-55. PubMed ID: 6920328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Micro-glandular hyperplasia of the uterine cervix. Histo-cytopathological evaluation, differential diagnosis and review of literature].
    Daniele E; Nuara R; Morello V; Nagar C; Tralongo V; Tomasino RM
    Pathologica; 1993; 85(1100):607-35. PubMed ID: 8170711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenocarcinoma-like lesion of cervix--a "pill-induced" problem?
    Talbert JR; Sherry JB
    Am J Obstet Gynecol; 1969 Sep; 105(1):117-20. PubMed ID: 5805241
    [No Abstract]   [Full Text] [Related]  

  • 59. Cytologic and biopsy findings leading to conization in adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Obstet Gynecol; 2002 Aug; 100(2):271-6. PubMed ID: 12151149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.